Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gary Mohilner who wrote (392)	10/30/2016 3:56:14 PM
From: Gary Mohilner	Read Replies (1) of 684

When I posted the original message IMGN was trading for more than its cash per share, now it's trading for less. They have reorganized, laid off some people, and still they've had no further negative clinical news, yet the price is now dramatically below their cash holdings per share. In short, I believe it's greatly under priced. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next